腕隧道症候群治疗的全球市场(2022年～2029年)

本报告提供全球腕隧道症候群治疗市场相关调查分析，提供市场动态，产业分析，市场分析，竞争情形等系统性资讯。

目录

第1章 全球腕隧道症候群治疗的调查手法和范围

• 调查手法
• 调查的目的和调查范围

第2章 全球腕隧道症候群治疗市场-市场定义和概要

第3章 全球腕隧道症候群治疗市场-摘要整理

• 市场明细:各产品类型
• 市场明细:各终端用户
• 市场明细:各地区

第4章 全球腕隧道症候群治疗市场-市场动态

• 影响市场的要素
  • 促进因素
  • 阻碍因素
  • 市场机会
  • 影响分析

第5章 全球腕隧道症候群治疗市场-产业分析

• 波特的五力分析
• 供应链分析
• 价格分析
• 法规分析
• PEST分析

第6章 全球腕隧道症候群治疗市场-COVID-19分析

• 市场COVID-19分析
  • COVID-19前的市场方案
  • 目前COVID-19市场方案
  • COVID-19后的市场方案/未来市场方案
• COVID-19的价格的动态
• 需求与供给的频谱
• 政府在COVID-19疫情下的市场相关措施
• 製造商策略性举措
• 结论

第7章 全球腕隧道症候群治疗市场:各产品类型

• 简介
  • 市场规模分析，及与前一年同期比较成长分析(%):各产品类型
  • 市场魅力指数:各产品类型
• 开放式腕管释放系统*
  • 简介
  • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年)
• 内视镜下腕管释放系统

第8章 全球腕隧道症候群治疗市场:各终端用户

• 简介
  • 市场规模分析，及与前一年同期比较成长分析(%):各终端用户
  • 市场魅力指数:各终端用户
• 门诊病人手术中心*
  • 简介
  • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年)
• 医院
• 其他

第9章 全球腕隧道症候群治疗市场:各地区

• 简介
  • 市场规模分析，100万美元(2020年～2029年)，及与前一年同期比较成长分析(%)(2021年～2029年):各地区
  • 市场魅力指数:各地区
• 北美
• 欧洲
• 南美
• 亚太地区
• 中东和非洲

第10章 全球腕隧道症候群治疗市场-竞争情形

• 竞争模式
• 主要的开发与策略
• 企业占有率分析
• 产品的基准
• 值得注意的主要企业
• 颠覆性技术的企业

第11章 全球腕隧道症候群治疗市场-企业简介概要

• Integra LifeSciences Corporation*
  • 企业概要
  • 产品系列及说明
  • 主要亮点
  • 财务概要
• AM Surgical Inc
• Arthrex, Inc
• CONMED Corporation
• Medical Designs, LLC
• MicroAire Surgical Instruments, LLC
• Smith & Nephew plc
• Stryker Corporation
• Trice Medical

第12章 全球腕隧道症候群治疗市场-DataM

• 附录
• 关于本公司·服务
• 咨询方式

Market Overview The global carpal tunnel syndrome treatment market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Carpal tunnel release is a surgery used to treat and potentially heal the painful condition known as carpal tunnel syndrome. A proper diagnosis of carpal tunnel syndrome is the primary reason for carpal tunnel surgery. Carpal tunnel release is generally an outpatient procedure, which means that one can go home the same day as the surgery if all goes well. There are two types of carpal tunnel release surgery, i.e., open and endoscopic.

Market Dynamics

The global carpal tunnel syndrome treatment market growth is driven by the increasing prevalence of carpal tunnel syndrome (CTS) and lower procedure costs and improved medical reimbursement coverage for CT surgeries.

Lower procedure costs and improved medical reimbursement coverage for CT surgeries is expected to hold the largest share in this market segment

Better medical reimbursement coverage and lower expenses on healthcare have also bolstered the demand for carpal tunnel release in the past few years. Due to the availability of efficient and effective products, the demand for carpal tunnel treatment for the CTR procedures. The leading players of the market are merging with manufacturing organizations on contract basis in order to develop efficient products as per the particular treatment requires.

An important factor expected to boost the global carpal tunnel release market is the affordability of emergency rooms CTR systems in the market. Also, the new emergency rooms are now equipped with better technological devices so as to provide services of a higher class and that too at reasonable prices. Apart from that, the increase in the number of geriatric population all over the world and especially in the developing nations is expected to open new doors of opportunity for surgical procedures of greater quality. The advancement of CTR surgeries accompanied by endoscopic methods have accelerated the comprehensive growth of carpal tunnel release systems market globally.

High cost of surgical procedures can hinder the market growth

According to the American Academy of Orthopaedic Surgeons, Carpal tunnel syndrome has a prevalence of nearly 4 percent in the United States, leading to over 600,000 CTR procedures every year. A total of 10,173 claims were identified, with a mean charge per claim of $4,780. The use of general anesthesia was associated with higher charges compared to local anesthesia. The location of the surgery also affected costs: charges for surgeries performed in an HOPD were approximately 51 percent higher than those performed in an ASC.

COVID-19 Impact Analysis

It is 2022, and the COVID-19 induced pandemic is far from over. Scientists worldwide continue to detect newer mutations (variants) of the virus and develop vaccines to try and reduce the impact of the virus on our lives. However, the pandemic has completely transformed how we lived, worked and led our lives. Offices are (in some cases) permanently shut, working and studying from home is the new norm. Long hours of work and time spent binge-watching TV or content online have also given rise to disorders that were earlier only heard of in isolated cases. Names such as Carpal Tunnel Syndrome, Dry Eye Syndrome, Repetitive Stress Injuries, Cervical Spondylitis and sleep disorders are now commonplace, affecting nearly 30% of those working from home for the first time.

Segment Analysis

The ambulatory surgical centres segment is expected to hold the largest share in this market segment

Ambulatory care or outpatient care is medical care provided on an outpatient basis. Throughout the past few decades, surgery has been increasingly prioritized by the global health community or governments, even in low- and middle-income countries. As a result, the number of surgical procedures has risen significantly to address the global disease burden, including carpal tunnel syndrome, thus leading to a rise in the utilization and adoption of carpal tunnel release systems.

Over the past few years, with the move to value-based care, hospitals and healthcare systems have faced extreme competition from mobile service sites, particularly those that offer physician office-based procedures and ambulatory surgery. Gaining in popularity across the globe, ambulatory surgery centers (ASCs) provide both operational and economic efficiencies, enabling ease of patient access, very competitive pricing, and increased opportunities for physician engagement. Thus, with the increasing number of carpal tunnel release surgeries, the studied market is expected to increase in the future.

Geographical Analysis

North America region holds the largest market share of global carpal tunnel syndrome treatment market

North American dominates the Carpal Tunnel Release Systems products market primarily due to high awareness regarding such health conditions. In addition, the rising prevalence of the condition is also fueling the market growth across the region.

According to the 2020 article, titled "Carpal Tunnel Syndrome" (Justin O. Sevy; Matthew Varacallo), in the United States, carpal tunnel syndrome has an incidence of 1 to 3 persons per 1000 per year, with a prevalence of 50 per 1000, with similar incidence and prevalence in most developed countries (2018). It most commonly affects whites, has up to a 10 to 1 predominance in females, and has a peak age of 46 to 60.

Competitive Landscape

The global carpal tunnel syndrome treatment market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include AM Surgical Inc., Arthrex, Inc., CONMED Corporation, Integra LifeSciences Corporation, Medical Designs, LLC, MicroAire Surgical Instruments, LLC., Smith & Nephew plc, Stryker Corporation, Trice Medical.

Integra LifeSciences

Overview: Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, and reconstructive and general surgery. Integra advanced wound care is focused on research and innovation for the management of acute or chronic wounds and burns.

Product Portfolio: It includes products like SafeGuard Mini Carpal Tunnel Release System.

Why Purchase the Report?

Visualize the composition of the carpal tunnel syndrome treatment market segmentation by product type, end-user and region highlighting the key commercial assets and players.

Identify commercial opportunities in carpal tunnel syndrome treatment market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of carpal tunnel syndrome treatment market - level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players.

The global carpal tunnel syndrome treatment market report would provide an access to an approx. 49 market data table, 50 figures and 200 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

1. Global Carpal Tunnel Syndrome Treatment Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Carpal Tunnel Syndrome Treatment Market - Market Definition and Overview

3. Global Carpal Tunnel Syndrome Treatment Market - Executive Summary

• 3.1. Market Snippet by Product Type
• 3.2. Market Snippet by End-User
• 3.3. Market Snippet by Region

4. Global Carpal Tunnel Syndrome Treatment Market - Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers:
    • 4.1.1.1. Lower Procedure Costs and Improved Medical Reimbursement Coverage for CT Surgeries
  • 4.1.2. Restraints:
    • 4.1.2.1. High cost of surgical procedures
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Global Carpal Tunnel Syndrome Treatment Market - Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. PEST Analysis

6. Global Carpal Tunnel Syndrome Treatment Market - COVID-19 Analysis

• 6.1. Analysis of Covid-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid Covid-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Global Carpal Tunnel Syndrome Treatment Market - By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Open Carpal Tunnel Release System*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 7.3. Endoscopic Carpal Tunnel Release System

8. Global Carpal Tunnel Syndrome Treatment Market - By End-user

• 8.1. Introduction
  • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-user
  • 8.1.2. Market Attractiveness Index, By End-user
• 8.2. Ambulatory Surgical Centres*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
• 8.3. Hospitals
• 8.4. Others

9. Global Carpal Tunnel Syndrome Treatment Market - By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. U.K.
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. Australia
    • 9.5.5.5. Rest of Asia Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

10. Global Carpal Tunnel Syndrome Treatment Market - Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Key Developments and Strategies
• 10.3. Company Share Analysis
• 10.4. Product Benchmarking
• 10.5. Key Companies to Watch
• 10.6. Company with disruptive technology

11. Global Carpal Tunnel Syndrome Treatment Market- Company Profiles

• 11.1. Integra LifeSciences Corporation*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. AM Surgical Inc
• 11.3. Arthrex, Inc
• 11.4. CONMED Corporation
• 11.5. Medical Designs, LLC
• 11.6. MicroAire Surgical Instruments, LLC
• 11.7. Smith & Nephew plc
• 11.8. Stryker Corporation
• 11.9. Trice Medical

LIST NOT EXHAUSTIVE

12. Global Carpal Tunnel Syndrome Treatment Market - DataM

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us